Cardiovascular, Renal and Metabolic

PATHOLOGIES

  • Type 2 diabetes
  • Acute coronary syndrome
  • Dyslipidemia
  • Hypertension

* Specific content soon

Webinars & Events

We invite you to access the section of Webinars & Upcoming and Live Events. Keep up to date with the main medical congresses and events.

Videos On Demand

We invite you to access the Videos On Demand section categorized according to therapeutic area, along with our archive of videos and past highlighted events.

Cardiovascular, Renal and Metabolic

AstraZeneca has been driving innovation in the cardiovascular field for more than 100 years. Despite improvements in the diagnosis and treatment of cardiovascular disease and metabolic disease (CVMD), unmet medical needs remain high. AstraZeneca follows the science to transform the way cardiovascular disease (CVD), chronic kidney disease (CKD) and diabetes and its interactions are understood to put the focus of treatment in comprehensive care (CaReMe: Cardio-Renal-Metabolic), with the patient at the center, achieving prevention and delaying the progression of metabolic cardiorenal disease (CVMD) being the prinicpal objective of treatment.